GLP-1 receptor agonists like semaglutide do not simply help women lose weight and call it a day
New or worsening injection site reactionsincluding increased pain, swelling, redness, or nodule formationshould be reported to a healthcare provider
Semaglutide: A GLP-1 Receptor Agonist Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist , which means it mimics a natural hormone that helps regulate blood sugar and appetite
The two used for injections, hydroxocobalamin and cyanocobalamin, have different storage rules, and getting them mixed up is the usual source of confusion
It is knowing which patient needs a GLP-1 and which one needs a workup, how to titrate through the nausea window without losing the patient, how to protect lean mass during rapid loss, how to screen for the contraindications that matter, and how to tell a patient honestly what an adjunct will and will not do for them
For patients who are straightforward candidates, meaning no significant comorbidities, no psychiatric history, no prior GI disease, no eating disorder history, and no drug-drug interaction concerns, Mochi Health's model may be sufficient to deliver the clinical contact points the AACE recommends